• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Legal & General Future World ESG UK Index Fund I Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderLegal & General(Unit Trust Managers)Ltd
Fund SummaryThe investment objective of the Fund is to seek to provide both capital growth and income by tracking the performance of the Solactive L&G ESG UK Index (the ™Index™). The Fund invests almost exclusively in the shares of companies that make up the Index. The index aims to explicitly incorporate environmental, social and governance considerations into the investment strategy.
SEDOL codeBJH4X97
ISINGB00BJH4X975
Fund codeLGWUI
ManagersJason Forster
Manager Tenure1 year
Morningstar CategoryUK Large-Cap Equity
IMA SectorUK All Companies
Fund Size£238 million
Fund TypeOEIC
Management StylePassive
Ongoing Charge Figure (OCF)0.22%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£0.0041
Buy Price£0.0041
Price Date24th September 2020
YieldCurrently unavailable
Dividend FrequencySemi-Annually
ISA EligibleYes
SIPP EligibleYes
Inception Date10th August 2020
Fund StatusOPEN
Jason Forster is a Senior Fund Manager in Index Funds and heads up the team responsible for the fund management of the UK and Asian regions. Jason was formerly responsible for the development of the in-house index fund management system before becoming a Fund Manager in 2002. Prior to joining LGIM in 1999, Jason worked for Hermes Fund Management and was involved in portfolio performance measurement. Prior to Hermes, Jason gained valuable experience working for FTSE International for over two years as an indices analyst. He began his career in 1992, working for the Financial Times as a news text editor and then as a prices editor. Jason completed Business Studies at Southampton Solent University and is a member of the LPX Index Committee and the FTSE EMEA Regional Committee.

3-year Mean Monthly Return: Currently unavailable

Annual Returns2019
Fund Performance-12.96%
Benchmark Performance
(UK Large-Cap Equity)
-12.42%
Time PeriodCumulativeBenchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day-1.44%-20.00%+18.56%
1 week-2.78%-3.63%+0.85%
1 month-3.80%-3.07%-0.73%
3 months-4.14%+17.56%-21.70%
6 months14.15%-15.49%+29.64%
1 year-17.41%-10.67%-6.74%
3 yearsCurrently unavailableCurrently unavailableCurrently unavailable
5 yearsCurrently unavailableCurrently unavailableCurrently unavailable
10 yearsCurrently unavailableCurrently unavailableCurrently unavailable
YTD-20.33%-3.07%-17.26%
Since inception-11.02%Currently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
AstraZeneca PLCGBR7.31%
GlaxoSmithKline PLCGBR5.36%
Diageo PLCGBR5.04%
HSBC Holdings PLCGBR4.93%
Reckitt Benckiser Group PLCGBR3.50%
Unilever PLCGBR3.40%
RELX PLCGBR3.38%
British American Tobacco PLCGBR3.33%
BP PLCGBR2.56%
Rio Tinto PLCGBR2.21%
Dividend DatePer share amountReinvestment Price
1st April 20200.0082£0.3730
1st October 20190.0100£0.5046